Masked cancer drug trains immune system to kill tumors while sparing healthy tissues

Many cancer treatments are notoriously savage on the body. Drugs often attack both healthy cells and tumor cells, causing a plethora of side effects. Immunotherapies that help the immune system recognize and attack cancer cells are no different. Though they have prolonged the lives of countless patients, they work in only a subset of patients. One study found that fewer than 30% of breast cancer patients respond to one of the most common forms of immunotherapy.

But what if drugs could be engineered to attack only tumor cells and spare the rest of the body? To that end, my colleagues and I at the University of Chicago’s Pritzker School of Molecular Engineering have designed a method to keep one promising cancer drug from wreaking havoc by “masking” it until it reaches a tumor....

Popular posts from this blog

Third degree torture used on Maruti workers: Rights body

Haruki Murakami: On seeing the 100% perfect girl one beautiful April morning

The Almond Trees by Albert Camus (1940)

Rudyard Kipling: critical essay by George Orwell (1942)

Satyagraha - An answer to modern nihilism

Albert Camus's lecture 'The Human Crisis', New York, March 1946. 'No cause justifies the murder of innocents'

Goodbye Sadiq al-Azm, lone Syrian Marxist against the Assad regime